Synopsis The global Obstetric Ultrasonic Transducer market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Obstetric ultrasonic transducer is a specialized .....
SynopsisAdult ADHD, or Attention Deficit Hyperactivity Disorder in adults, is a neurodevelopmental condition characterized by symptoms such as inattention, hyperactivity, and impulsiveness. Treatment for adult ADHD typically involves a combination of medication, psych.....
SynopsisThe global Bacterial Vaginosis Detector market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Bacterial Vaginosis Detector is estima.....
SynopsisThe global Depression-MDD Drugs market was valued at US$ 17130 million in 2023 and is anticipated to reach US$ 19910 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in .....
SynopsisRib Fracture Repair Systems are devices and implants designed to support the reconstruction of a fractured rib. The devices are primarily made up of titanium alloys and stainless steel coated by the polymer. The novel type of core internal fixation implants an.....
Synopsis It is mainly used to detect endotoxins in injectable drugs, biological products and medical devices. They are also used in kidney dialysis centers and a wide range of other applications. Highlights The global Bacte.....
SynopsisThe global Oral COVID-19 Antiviral Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oral COVID-19 Antiviral Medicine in various end use indus.....
Synopsis Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.It serves to stimulate the production .....
SynopsisThe global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Glutamate Receptor Ionotropi.....
SynopsisThe global Lower Extremity Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Lower Extremity Devices is estimated to in.....
